BlackRock Fund Advisors’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$88M Buy
1,595,829
+160,017
+11% +$8.78M 0.02% 1299
2016
Q3
$81.1M Buy
1,435,812
+74,747
+5% +$3.67M 0.02% 1236
2016
Q2
$56.8M Buy
1,361,065
+96,272
+8% +$4.44M 0.01% 1399
2016
Q1
$54.1M Buy
1,264,793
+72,562
+6% +$3.07M 0.01% 1405
2015
Q4
$54M Buy
1,192,231
+713,908
+149% +$30M 0.01% 1418
2015
Q3
$18.6M Sell
478,323
-4,200
-0.9% -$168K ﹤0.01% 2036
2015
Q2
$17.5M Sell
482,523
-13,234
-3% -$419K ﹤0.01% 2196
2015
Q1
$14.3M Buy
495,757
+9,764
+2% +$272K ﹤0.01% 2248
2014
Q4
$11.8M Buy
+485,993
New +$11M ﹤0.01% 2360

Other funds holding PRAH

BlackRock Fund Advisors's PRAH Position: Q4 2016 in Review

BlackRock Fund Advisors increased its PRA Health Sciences, Inc. (PRAH) stake by 11% in Q4 2016, buying an estimated $8.78M and bringing the position to 1,595,829 shares worth $88M. The position accounts for 0.02% of the portfolio, ranked #1299.

BlackRock Fund Advisors first reported a position in PRAH in Q4 2014 and has held it in 9 quarters since. 188 funds tracked by Wall St. Rank hold PRAH as of Q4 2016.

  • BlackRock Fund Advisors held 1,595,829 shares of PRA Health Sciences, Inc. worth $88M as of Q4 2016.
  • BlackRock Fund Advisors bought 160,017 PRA Health Sciences, Inc. shares in Q4 2016, an estimated $8.78M.
  • PRA Health Sciences, Inc. made up 0.02% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1299 holding.
  • BlackRock Fund Advisors first reported a position in PRA Health Sciences, Inc. in Q4 2014 and has held it in 9 quarters since.
  • 188 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.